Madeleine R. Heldman, MD, MS, discusses managing cytomegalovirus, including advances in CMV assessment and antiviral and immune strategies.

The Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), since the experiments in rodents in the 50’s, has become a ...

The frustrating part is that you can't predict how long it will take' says Frenchman, who has yet to race in 2025 ...

The patient died of acute liver failure; the maker of the gene therapy noted that the patient also had a recent ...

This case emphasises the need for early recognition and proper diagnosis of CHIKV infection in patients with acute joint pain ...

Sarepta stock may recover sharply as additional information and data reveal that the adverse event reported by the company is ...

Natural killer cell deficiency should be considered in patients susceptible to herpes virus or papillomavirus with persistently decreased NK cell function.

We recently published a list of 10 Firms Heavily Hit by Market Pessimism. In this article, we are going to take a look at ...

The patient died after experiencing acute liver failure. Testing showed he also had a recent cytomegalovirus (CMV) infection, ...

Sarepta Therapeutics said on Tuesday that a 16-year-old boy died from acute liver failure months after receiving the company's U.S-approved gene therapy for a rare muscular dystrophy.

Sarepta Therapeutics Inc.'s stock tumbled 23% on Tuesday after the biotech said a patient who used its gene therapy Elevidys for the rare disease Duchenne muscular dystrophy has died of acute liver ...

Shares of Sarepta Therapeutics (SRPT) are under pressure on Tuesday after the company shared a safety update related to its Elevidys, the only ...